| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0041-008X(02)00022-4 |
| P698 | PubMed publication ID | 12583988 |
| P50 | author | Michael P. Waalkes | Q113460555 |
| P2093 | author name string | Jie Liu | |
| Jerrold M Ward | |||
| Bhalchandra A Diwan | |||
| P2860 | cites work | Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors | Q23912223 |
| Cancer risks from arsenic in drinking water | Q24554413 | ||
| Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors | Q26341280 | ||
| Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression | Q28379242 | ||
| A concise review of the toxicity and carcinogenicity of dimethylarsinic acid | Q29012941 | ||
| Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes | Q33891890 | ||
| Methylated trivalent arsenic species are genotoxic | Q33942554 | ||
| Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 | ||
| Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. | Q34093044 | ||
| Stress proteins induced by arsenic. | Q34104768 | ||
| Genetic toxicology of a paradoxical human carcinogen, arsenic: a review | Q34245571 | ||
| The cellular metabolism and systemic toxicity of arsenic | Q34401625 | ||
| Drinking water arsenic in Utah: A cohort mortality study | Q35029875 | ||
| Risk of internal cancers from arsenic in drinking water | Q35135577 | ||
| Arsenic ingestion and internal cancers: a review | Q36039612 | ||
| Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity | Q41455778 | ||
| Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases | Q43478126 | ||
| Operational reversibility is a key aspect of carcinogenesis | Q43806758 | ||
| Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India | Q44683557 | ||
| Transplacental carcinogenic effects of nickel(II) acetate in the renal cortex, renal pelvis and adenohypophysis in F344/NCr rats | Q46367539 | ||
| Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. | Q52580196 | ||
| Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. | Q53408366 | ||
| Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. | Q53422188 | ||
| Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital. | Q53464055 | ||
| Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells | Q56114256 | ||
| Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro | Q71378242 | ||
| Strain-dependent disposition of inorganic arsenic in the mouse | Q73082626 | ||
| The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice | Q73644184 | ||
| Mortality for certain diseases in areas with high levels of arsenic in drinking water | Q78115942 | ||
| Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats | Q78198416 | ||
| P433 | issue | 1 | |
| P921 | main subject | drinking water | Q7892 |
| arsenic | Q871 | ||
| P304 | page(s) | 7-17 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice | |
| P478 | volume | 186 |
| Q36768351 | Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic |
| Q35733075 | Alteration of mammary gland development and gene expression by in utero exposure to arsenic |
| Q86496512 | Antioxidant and modulatory role of Chlorophytum borivilianum against arsenic induced testicular impairment |
| Q38732732 | Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex. |
| Q28389347 | Arsenic Toxicity in Male Reproduction and Development |
| Q90231178 | Arsenic aggravated reproductive toxicity in male rats exposed to lead during the perinatal period |
| Q89730716 | Arsenic and benzo[a]pyrene co-exposure acts synergistically in inducing cancer stem cell-like property and tumorigenesis by epigenetically down-regulating SOCS3 expression |
| Q28387404 | Arsenic and cardiovascular disease |
| Q28383459 | Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis |
| Q28392204 | Arsenic exposure and toxicology: a historical perspective |
| Q43071433 | Arsenic exposure in utero and nonepidermal proliferative response in adulthood in Tg.AC mice |
| Q44641888 | Arsenic in water, food and cigarettes: a cancer risk to Pakistani population |
| Q35591935 | Arsenic toxicology: translating between experimental models and human pathology |
| Q34593837 | Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer |
| Q28386272 | Arsenic-Associated Changes to the Epigenome: What Are the Functional Consequences? |
| Q92372143 | Arsenic-Induced Carcinogenesis and Immune Dysregulation |
| Q37231348 | Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures |
| Q28384235 | Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite |
| Q24815464 | Assessing susceptibility from early-life exposure to carcinogens |
| Q42376731 | Assessment of the Effects of Graded Doses of Polyphenolic-Rich Fraction of Garcinia kola Seeds on Pituitary-Testicular Axis of Male Wistar Rats |
| Q28386100 | Associations between Blood and Urine Arsenic Concentrations and Global Levels of Post-Translational Histone Modifications in Bangladeshi Men and Women |
| Q42702133 | Augmenting effects of gestational arsenite exposure of C3H mice on the hepatic tumors of the F₂ male offspring via the F₁ male offspring |
| Q22299212 | Benzene-induced cancers: abridged history and occupational health impact |
| Q24813432 | Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice |
| Q35879729 | Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China |
| Q39723198 | CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water |
| Q39402634 | Cadmium suppresses the proliferation of piglet Sertoli cells and causes their DNA damage, cell apoptosis and aberrant ultrastructure |
| Q28385426 | Can folate intake reduce arsenic toxicity? |
| Q28387869 | Cancer in experimental animals exposed to arsenic and arsenic compounds |
| Q90177042 | Cancer prevention programmes in Mexico: are we doing enough? |
| Q24707869 | Carcinogenic Effects of “Whole-Life” Exposure to Inorganic Arsenic in CD1 Mice |
| Q41917722 | Co-administration of sodium arsenite and ethanol: Protection by aqueous extract of Aframomum longiscapum seeds |
| Q35894641 | Comet assay evaluation of six chemicals of known genotoxic potential in rats |
| Q42688530 | Comment on "Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice". |
| Q92555901 | Comparison of carcinogenic potency across life stages: implications for the assessment of transplacental cancer risk |
| Q48403728 | Comparison of speciated arsenic levels in the liver and brain of mice between arsenate and arsenite exposure at the early life |
| Q91650177 | Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans |
| Q92868409 | DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice |
| Q48461633 | Decreased nitric oxide production in the rat brain after chronic arsenic exposure. |
| Q36509012 | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure |
| Q49349619 | Developmental Windows of Susceptibility to Inorganic Arsenic: A Survey of Current Toxicologic and Epidemiologic Data. |
| Q46235551 | Differential oxidative stress and DNA damage in rat brain regions and blood following chronic arsenic exposure |
| Q37392124 | Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. |
| Q33976810 | Dose-responsive gene expression changes in juvenile and adult mummichogs (Fundulus heteroclitus) after arsenic exposure |
| Q33779200 | Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. |
| Q61799501 | Effects of Developmental Arsenic Exposure on the Social Behavior and Related Gene Expression in C3H Adult Male Mice |
| Q28395938 | Effects of arsenic exposure on DNA methylation and epigenetic gene regulation |
| Q36423797 | Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line |
| Q25257026 | Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action |
| Q36675531 | Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice. |
| Q28385068 | Effects of low-dose drinking water arsenic on mouse fetal and postnatal growth and development |
| Q39149248 | Effects of prenatal exposure to endocrine disruptors and toxic metals on the fetal epigenome |
| Q92379608 | Environmental Epigenetic Changes, as Risk Factors for the Development of Diseases in Children: A Systematic Review |
| Q89716070 | Environmental exposures, stem cells, and cancer |
| Q34138716 | Environmental toxicants and the developing immune system: a missing link in the global battle against infectious disease? |
| Q28385295 | Environmental toxicants, epigenetics, and cancer |
| Q34371580 | Evaluation of the carcinogenicity of inorganic arsenic |
| Q43295840 | Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal |
| Q28389068 | Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure |
| Q36003455 | Further evidence against a direct genotoxic mode of action for arsenic-induced cancer |
| Q33651628 | Genetic integrity of the human Y chromosome exposed to groundwater arsenic |
| Q34583834 | Genome-wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic |
| Q42708957 | Genome-wide analysis of DNA methylation changes induced by gestational arsenic exposure in liver tumors. |
| Q91464093 | Genome-wide epigenetic signatures of childhood adversity in early life: Opportunities and challenges |
| Q25256866 | Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure |
| Q34014669 | HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota |
| Q51425265 | Hepatoprotective role of vitamin B(12) and folic acid in arsenic intoxicated rats. |
| Q28395561 | Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks |
| Q34060063 | Impact of environmental chemicals on lung development |
| Q36393258 | Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice |
| Q57929665 | Impact of prenatal arsenic exposure on chronic adult diseases |
| Q46552512 | In Vivo and In Vitro Arsenic Exposition Induces Oxidative Stress in Anterior Pituitary Gland |
| Q28389104 | In utero and early life arsenic exposure in relation to long-term health and disease |
| Q28388283 | In utero and postnatal exposure to arsenic alters pulmonary structure and function |
| Q26799414 | In utero arsenic exposure in mice and early life susceptibility to cancer |
| Q28396600 | In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- mice |
| Q34590719 | In utero exposure to low dose arsenic via drinking water impairs early life lung mechanics in mice |
| Q44620655 | Induction of structural and numerical changes of chromosome, centrosome abnormality, multipolar spindles and multipolar division in cultured Chinese hamster V79 cells by exposure to a trivalent dimethylarsenic compound. |
| Q34290958 | Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA |
| Q37331212 | Influence of prenatal lead exposure on genomic methylation of cord blood DNA. |
| Q28396050 | Inorganic arsenic as a developmental toxicant: in utero exposure and alterations in the developing rat lungs |
| Q35164353 | Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. |
| Q42717465 | Late-onset increases in oxidative stress and other tumorigenic activities and tumors with a Ha-ras mutation in the liver of adult male C3H mice gestationally exposed to arsenic |
| Q35919663 | Lipid peroxidation in brain tissue following administration of low and high doses of arsenite and L-ascorbate in wistar strain rats. |
| Q28390690 | Liver is a target of arsenic carcinogenesis |
| Q50145722 | Long-Term Health Effects and Underlying Biological Mechanisms of Developmental Exposure to Arsenic |
| Q24707867 | Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses |
| Q53290186 | Maternal and fetal exposure to four carcinogenic environmental metals. |
| Q36567337 | Mechanisms Underlying Latent Disease Risk Associated with Early-Life Arsenic Exposure: Current Research Trends and Scientific Gaps. |
| Q34567906 | Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment |
| Q37691160 | Methylation of inorganic arsenic by murine fetal tissue explants |
| Q41055755 | N-acetylcysteine effectively mitigates cadmium-induced oxidative damage and cell death in Leydig cells in vitro. |
| Q48118340 | NF-κB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite |
| Q42730519 | NRF2 Is a Potential Modulator of Hyperresistance to Arsenic Toxicity in Stem-Like Keratinocytes |
| Q37029787 | Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity |
| Q37398906 | Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects |
| Q89747964 | PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity |
| Q36747763 | Prenatal Exposure to Arsenic Impairs Behavioral Flexibility and Cortical Structure in Mice |
| Q28728378 | Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis |
| Q36115356 | Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes |
| Q89597887 | Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water |
| Q39714568 | RKIP expression of liver and kidney after arsenic exposure |
| Q24707868 | Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice |
| Q42865026 | Reply to "Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b". |
| Q42688531 | Response to "Comment on 'Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice'". |
| Q54446181 | Results of a long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to sodium arsenite administered in drinking water. |
| Q39108700 | Review on arsenic-induced toxicity in male reproductive system and its amelioration |
| Q28392565 | Sex-specific patterns and deregulation of endocrine pathways in the gene expression profiles of Bangladeshi adults exposed to arsenic contaminated drinking water |
| Q28385528 | Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin |
| Q54942120 | The HER-2 as a Target Gene of Curcumin to Protect Hepatocytes Against the Arsenic-induced Carcinoma in Mice. |
| Q36339038 | The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic |
| Q28388257 | The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis |
| Q53295265 | The impact of recent advances in research on arsenic cancer risk assessment. |
| Q34217564 | The protective role of vitamin E on the testicular tissue in rats exposed to sodium arsenite during the prenatal stage till sex maturity: A stereological analysis |
| Q36929584 | The steroidogenic acute regulatory protein as a target of endocrine disruption in male reproduction |
| Q47549876 | Toxic elements as biomarkers for breast cancer: a meta-analysis study |
| Q34271126 | Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide |
| Q43263160 | Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic |
| Q28396711 | Transplacental arsenic carcinogenesis in mice |
| Q37187687 | Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism |
| Q37673493 | Tumor-augmenting effects of gestational arsenic exposure on F1 and F2 in mice |
| Q36281917 | Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice |
| Q34691948 | Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic |
Search more.